mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.61 |
0.04 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |